Chemical Compound

alprostadil

CAS Registry Number 745-65-3

Back to search Request a Quote

Primary Record

alprostadil

In stock: 5,576 g
Purity: 99.4 %
CAS: 745-65-3

Compound Identifiers & Properties

CAS: 745-65-3
PubChem CID: 5280723
SMILES: CCCCC[C@@H](/C=C/[C@H]1[C@@H](CC(=O)[C@@H]1CCCCCCC(=O)O)O)O
Canonical SMILES: CCCCC[C@H](O)/C=C/[C@H]1[C@H](O)CC(=O)[C@@H]1CCCCCCC(=O)O

Names & Synonyms

alprostadil
Prostaglandin E1
Edex
Caverject
Muse
PGE1
Prostavasin
Prostandin
Alprostadilum
Vasaprostan
Prostin VR
Topiglan
745-65-3
Befar
Liprostin
Femprox
Minprog
Vitaros
Prink
Lipoprost
Prostivas
Sugiran
Viridal
l-Prostaglandin E1
Alprox-TD
Prostin VR Pediatric
Promostan
Prostin
Alista
Liple
Palux
Caverject Impulse
FemLife
PGE1alpha
ProstaglandinE1
RayVa
Prostaglandine E
Alprostan
Alyprost
Caveject
Eglandin
Prostine VR
Viridal duo
PGE1 Oligomer
l-PGE1
Lipo-alprostadil
Alprostadil RS
Caverject (TN)
Lipo PGE1
Alprostadil CRS
SEPA-alprostadil
(-)-Prostaglandin E1
Prostaglandin K1
Alprox TD
Alprostadil(usan)
PGE-1
Viridal 5
Lipo-PGE1
Befar (TN)
Prink (TN)
Prostaglandin E1alpha
Prostandin 500
Alprostadil(Caverject)
Viridal 10
Viridal 20
Edex (TN)
Muse (TN)
Lipoprostaglandin E1
1-Prostaglandin E1
(-)-Protaglandin E1
AC1NQXHQ
SEPA-prostaglandin E1
CHEMBL495
PGE1;Prostaglandin E1
RefChem:56455
Alprostadilum [INN-Latin]
DTXSID9022578
SEPA-PGE1
Prostin VR pediatric (TN)
Prestwick2_001018
Prestwick3_001018
ALPROSTADIL [INN]
ALPROSTADIL [JAN]
Alprostadil Prostoglandin E1
GMVPRGQOIOIIMI-DWKJAMRDSA-N
ALPROSTADIL [USAN]
D0I4DQ
D0N2EF
ALPROSTADIL [VANDF]
Alprostadil [EP monograph]
PGE1 (Prostaglandin E1)
BML1-F06
DTXCID502578
ALPROSTADIL [MART.]
MFCD00077860
SCHEMBL33317
ALPROSTADIL [USP-RS]
ALPROSTADIL [WHO-DD]
BSPBio_001175
BSPBio_001488
UNII-F5TD010360
CHEBI:15544
MLS000758964
MLS001424250
ONO 1608
Alprostadil (ProstaglandinE1)
Alprostadil; Prostaglandin E1
BIDD:GT0747
HEI-507
MR-256
PROSTAGLANDIN E1 [MI]
1-PGE1
BPBio1_001293
GTPL1882
orb1307980
Alprostadil (JP15/USP/INN)
Alprostadil (JP18/USP/INN)
C20H34O5
F5TD010360
NSC 165559
ONO-1608
EINECS 212-017-2
ALPROSTADIL [ORANGE BOOK]
C01EA01
G04BE01
PGE1, Prostaglandin E1, powder
SYN3025
MR 256
ALPROSTADIL [USP IMPURITY]
GLXC-20048
HMS1361K10
HMS1571K17
HMS1791K10
HMS1989K10
HMS2052L11
HMS2090L08
HMS2098K17
HMS3268I09
HMS3402K10
HMS3414N09
HMS3648O17
HMS3678N07
HMS3715K17
(11alpha,13E,15S)-11,15-dihydroxy-9-oxoprost-13-en-1-oic acid
ALPROSTADIL [USP MONOGRAPH]
NSC-165559
Alprostadil [USAN:BAN:INN:JAN]
Alprostadil [USAN:INN:BAN:JAN]
AMY30076
BCP01740
EX-A1411
HY-B0131
MSK10682
ZINC3813088
Alprostadil [USAN:USP:INN:BAN:JAN]
Tox21_110482
U-10136
(C20-H34-O5)x-
11alpha,15alpha-Dihydroxy-9-oxo-13-trans-prostenoic acid
BDBM50101853
EBC-26712
LMFA03010134
NSC165559
s1508
9-oxo-11R,15S-dihydroxy-13E-prostaenoic acid
AKOS015961103
(13E)-(15S)-11alpha,15-Dihydroxy-9-oxoprost-13-enoate
AC-6095
ACN-036193
AI3-62116
BCP9000277
C20-H34-O5
CCG-101188
CID5280723
CS-1905
DB00770
FA31828
J3.319G
NC00438
RP17688
CID:5280723
IDI1_033958
SMP2_000271
U-10,136
NCGC00016535-01
NCGC00016535-19
NCGC00025234-02
NCGC00025234-03
NCGC00025234-04
NCGC00025234-05
AS-16360
BC205461
CAS-745-65-3
CPD000112594
K274
Prostaglandin E1, PGE1, 745-65-3
SAM001246840
SAM001246845
SAM001247093
SID:53790811
SMR000112594
U 10136
7-((1R,2R,3R)-3-hydroxy-2-((S,E)-3-hydroxyoct-1-en-1-yl)-5-oxocyclopentyl)heptanoic acid
Alprostadil 100 microg/mL in Acetonitrile
(13E,15S)-11alpha,15-dihydroxy-9-oxoprost-13-en-1-oic acid
AB0014134
AB2000131
Muse (intraurethral alprostadil suppository)
11,15-Dihydroxy-9-oxoprost-13-en-1-oate
AB00514004
B2154
NS00009541
P1917
ST50826271
Alprostadil, meets USP testing specifications
A11820
C04741
C76381
D00180
Prostaglandin E1, >=98% (HPLC), synthetic
Prostaglandin E1;Edex;Muse;Liprostin;Caverject
11,15-Dihydroxy-9-oxoprost-13-en-1-oic acid
AB00514004-06
AB00514004-08
AB00514004_09
7-[(1R,2R,3R)-3-hydroxy-2-[(E,3S)-3-hydroxyoct-1-enyl]-5-oxocyclopentyl]heptanoic acid
745P653
A838163
D000527
EN300-22411483
Prost-13-en-1-oic acid, 11,15-dihydroxy-9-oxo-, (11alpha,13E,15S)-
Q579348
SR-01000597593
SR-01000946253
SR-01000597593-1
SR-01000597593-5
SR-01000597593-6
SR-01000946253-1
BRD-K52459643-001-06-0
BRD-K52459643-001-10-2
BRD-K52459643-001-15-1
BRD-K52459643-001-17-7
(13E)-(15S)-11,15-dihydroxy-9-oxoprost-13-enoate
(13E)-(15S)-11,15-dihydroxy-9-oxoprost-13-enoic acid
11alpha,15(S)-Dihydroxy-9-oxo-13-trans-prostenoic acid
3-Hydroxy-2-(3-hydroxy-1-octenyl)-5-oxocyclopentaneheptanoic acid
Alprostadil, European Pharmacopoeia (EP) Reference Standard
B0084-299024
l-3-Hydroxy-2-(3-hydroxy-1-octenyl)-5-oxocyclopentaneheptanoic acid
(13E)-(15S)-11-alpha,15-dihydroxy-9-oxoprost-13-enoate
(13e)-(15s)-11alpha,15-dihydroxy-9-oxoprost-13-enoic acid
Cyclopentaneheptanoic acid, 3-hydroxy-2-(3-hydroxy-1-octenyl)-5-oxo-, (-)-
Prost-13-en-1-oic acid, 11,15-dihydroxy-9-oxo-, (11.alpha.,13E,15S)-
(11?,13E,15S)-11,15-Dihydroxy-9-oxo-prost-13-en-1-oic acid
(11|_,13E,15S)-11,15-Dihydroxy-9-oxoprost-13-en-1-oic acid
(11|A,13E,15S)-11,15-Dihydroxy-9-oxoprost-13-en-1-oic acid
(11a,13E,15S)-11,15-Dihydroxy-9-oxoprost-13-en-1-oic acid
(11alpha,13E,15S)-11,15-Dihydroxy-9-oxoprost-13-enoic acid
(13E)-(15S)-11-alpha,15-dihydroxy-9-oxoprost-13-enoic acid
(1R,2R,3R)-3-Hydroxy-2-((E)-(3S)-3-hydroxy-1-octenyl)-5-oxocyclopentaneheptanoic acid
11,15-dihydroxy-9-oxoprost-13-en-1-oic acid (ACD/Name 4.0)
3-Hydroxy-2-(3-hydroxy-1-octenyl)-5-oxo-cyclopentaneheptanoate
3-Hydroxy-2-(3-hydroxy-1-octenyl)-5-oxo-cyclopentaneheptanoic acid
7-[(1r,3r)-3-Hydroxy-2-[(1e,3s)-3-Hydroxyoct-1-En-1-Yl]-5-Oxocyclopentyl]heptanoic Acid
Alprostadil, United States Pharmacopeia (USP) Reference Standard
(+)-3-hydroxy-2-(3-hydroxy-1-octenyl)-5-oxo-Cyclopentaneheptanoate
(+)-3-hydroxy-2-(3-hydroxy-1-octenyl)-5-oxo-Cyclopentaneheptanoic acid
(-)-3-hydroxy-2-(3-hydroxy-1-octenyl)-5-oxo-Cyclopentaneheptanoate
(-)-3-hydroxy-2-(3-hydroxy-1-octenyl)-5-oxo-Cyclopentaneheptanoic acid
(11-alpha,13E,15S)-11,15-Dihydroxy-9-oxoprost-13-en-1-oic acid
(11alpha,12alpha,13E,15S)-11,15-dihydroxy-9-oxoprost-13-en-1-oic acid
(8R,13E,15S)-11alpha,15-Dihydroxy-9-oxoprosta-13-ene-1-oic acid
3-Hydroxy-2-(3-hydroxy-1-octenyl)-5-oxo-cyclop entaneheptanoic acid
7-[(1R,2R,3R)-3-hydroxy-2-[(1E,3S)-3-hydroxyoct-1-en-1-yl]-5-oxocyclopentyl]heptanoic acid
Cyclopentaneheptanoic acid, 3-hydroxy-2-(3-hydroxy-1-octenyl)-5-oxo-, ()-
Cyclopentaneheptanoic acid, 3-hydroxy-2-(3-hydroxy-1-octenyl)-5-oxo-, l-
Cyclopentaneheptanoic acid, 3alpha-hydroxy-2-(3-hydroxy-1-octenyl)-5-oxo-
PGE1; Alprostadil; 9-oxo-11|A,15S-dihydroxy-prost-13E-en-1-oic acid
Prost-13-en-1-oic acid, 11,15-dihydroxy-9-oxo-, (11?,13E,15S)-
Prost-13-en-1-oic acid, 11,15-dihydroxy-9-oxo-, (11a,13E,15S)-
Prostaglandin E1, synthetic, powder, BioReagent, suitable for cell culture
(1R,2R,3R)-3-Hydroxy-2-[(E)-(3S)-3-hydroxy-1-octenyl]-5-oxocyclopentaneheptanoic acid
(1R,2R,3R)-3-Hydroxy-2-[(E,3S)-3-hydroxy-1-octenyl]-5-oxocyclopentaneheptanoic acid
7-((1R,2R,3R)-3-hydroxy-2-((E,3S)-3-hydroxyoct-1-enyl)-5-oxocyclopentyl)heptanoic acid
7-((1R,2R,3R)-3-hydroxy-2-((S,E)-3-hydroxyoct-1-enyl)-5-oxocyclopentyl)heptanoic acid
7-[(1R,2R,3R)-3-hydroxy-2-[(E,3S)-3-hydroxyoct-1-enyl]-5-oxo-cyclopentyl]heptanoic acid
Prost-13-en-1-oic acid, 11,15-dihydroxy-9-oxo-, (11alpha,13E,15S)-, homopolymer
Prostaglandin E1, powder, gamma-irradiated, BioXtra, suitable for cell culture
(Z)-7-[(1r,2r,3r)-3-Hydroxy-2-[(E,3s)-3-Hydroxyoct-1-Enyl]-5-Oxo-Cyclopentyl]hept-5-Enoic Acid
119314-69-1
212-017-2
7-((1R,2R,3R)-3-Hydroxy-2-((1E,3S)-3-hydroxyoct-1-en-1-yl)-5-oxocyclopentyl)heptanoic acid
7-[5-((1E)(3S)-3-hydroxyoct-1-enyl)(1R,4R,5R)-4-hydroxy-2-oxocyclopentyl]hepta noic acid
Alprostadil; 7-[(1R,2R,3R)-3-Hydroxy-2-[(1E,3S)-3-hydroxyoct-1-enyl]-5-oxocyclopentyl]heptanoic acid
P2E
XPG